CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Virbac against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Injectable Isoxazoline Pharmaceutical Compositions And Their Use Against Parasite InfestationINTERVETSep 16, 2024
Injectable Pharmaceutical Compositions And Uses ThereofINTERVETJul 31, 2024
Containers For Compositions Comprising MeloxicamBOEHRINGER INGELHEIM VETMEDICAApr 25, 2024
Porcine Circovirus Type 2 (Pcv2) Subunit VaccineBOEHRINGER INGELHEIM ANIMAL HEALTH USAJul 25, 2023
Topical Localized Isoxazoline Formulation Comprising GlycofurolINTERVETOct 25, 2022
Topical Localized Isoxazoline FormulationINTERVETOct 25, 2022
Compositions Of Grapiprant And Methods For Using The SameARATANA THERAPEUTICSOct 25, 2022
Isoxazoline Compositions And Their Use As Antiparasitics For FelinesINTERVETFeb 11, 2022
Isoxazoline Compositions And Their Use As AntiparasiticsINTERVETDec 11, 2020
Antiparasitic Use Of Isoxazoline CompoundsINTERVETApr 3, 2020

Explore Virbac's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 27, 2017Porcine Circovirus Type-2 Subunit Vaccine1

Top competitors of Virbac

List of top competitors of Virbac based on patent oppositions.